SLGL
Sol-Gel Technologies (SLGL)
$13
About Sol-Gel Technologies (SLGL)
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Details
Daily high
$44.04
Daily low
$41.58
Price at open
$44.04
52 Week High
$52.26
52 Week Low
$4.02
Market cap
119.1M
Dividend yield
0.00%
Volume
9,480
Avg. volume
15,670
P/E ratio
-13.26
Sol-Gel Technologies News
Details
Daily high
$44.04
Daily low
$41.58
Price at open
$44.04
52 Week High
$52.26
52 Week Low
$4.02
Market cap
119.1M
Dividend yield
0.00%
Volume
9,480
Avg. volume
15,670
P/E ratio
-13.26